These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20840152)

  • 1. Epstein Barr virus inhibits the stimulatory effect of TLR7/8 and TLR9 agonists but not CD40 ligand in human B lymphocytes.
    Younesi V; Nikzamir H; Yousefi M; Khoshnoodi J; Arjmand M; Rabbani H; Shokri F
    Microbiol Immunol; 2010 Sep; 54(9):534-41. PubMed ID: 20840152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.
    Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P
    Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus.
    Martin HJ; Lee JM; Walls D; Hayward SD
    J Virol; 2007 Sep; 81(18):9748-58. PubMed ID: 17609264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
    Andersen JM; Al-Khairy D; Ingalls RR
    Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 7 cooperates with IL-4 in activated B cells through antigen receptor or CD38 and induces class switch recombination and IgG1 production.
    Tsukamoto Y; Nagai Y; Kariyone A; Shibata T; Kaisho T; Akira S; Miyake K; Takatsu K
    Mol Immunol; 2009 Apr; 46(7):1278-88. PubMed ID: 19157556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy between anti-CD40 MAb and Epstein-Barr virus in activation and transformation of human B lymphocytes.
    Tsuchiyama L; Kieran J; Boyle P; Wetzel GD
    Hum Antibodies; 1997; 8(1):43-7. PubMed ID: 9265505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation.
    Larangé A; Antonios D; Pallardy M; Kerdine-Römer S
    J Leukoc Biol; 2009 Apr; 85(4):673-83. PubMed ID: 19164127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-21 enhances the activity of the TLR-MyD88-STAT3 pathway but not the classical TLR-MyD88-NF-κB pathway in human B cells to boost antibody production.
    Liu BS; Stoop JN; Huizinga TW; Toes RE
    J Immunol; 2013 Oct; 191(8):4086-94. PubMed ID: 24043893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.
    Krieg AM; Vollmer J
    Immunol Rev; 2007 Dec; 220():251-69. PubMed ID: 17979852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR-mediated STAT3 and ERK activation controls IL-10 secretion by human B cells.
    Liu BS; Cao Y; Huizinga TW; Hafler DA; Toes RE
    Eur J Immunol; 2014 Jul; 44(7):2121-9. PubMed ID: 24737107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of CD40 and CD40 ligand in Epstein-Barr virus-infected T and NK cells and their role in cell survival.
    Imadome K; Shimizu N; Arai A; Miura O; Watanabe K; Nakamura H; Nonoyama S; Yamamoto K; Fujiwara S
    J Infect Dis; 2005 Oct; 192(8):1340-8. PubMed ID: 16170750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production.
    Glaum MC; Narula S; Song D; Zheng Y; Anderson AL; Pletcher CH; Levinson AI
    J Allergy Clin Immunol; 2009 Jan; 123(1):224-230.e4. PubMed ID: 18995892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the effect of TLR7/8, TLR9 agonists and CD40 ligand on the transformation efficiency of Epstein-Barr virus in human B lymphocytes by limiting dilution assay.
    Younesi V; Shirazi FG; Memarian A; Amanzadeh A; Jeddi-Tehrani M; Shokri F
    Cytotechnology; 2014 Jan; 66(1):95-105. PubMed ID: 23404520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system.
    Tedder TF; Goldmacher VS; Lambert JM; Schlossman SF
    J Immunol; 1986 Aug; 137(4):1387-91. PubMed ID: 3016095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR7/8 ligand, R-848, inhibits IgE synthesis by acting directly on B lymphocytes.
    Shen E; Lu L; Wu C
    Scand J Immunol; 2008 Jun; 67(6):560-8. PubMed ID: 18397197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of human B cell activation by TLR7 and TLR9 agonists.
    Hanten JA; Vasilakos JP; Riter CL; Neys L; Lipson KE; Alkan SS; Birmachu W
    BMC Immunol; 2008 Jul; 9():39. PubMed ID: 18652679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
    Marshall JD; Heeke DS; Gesner ML; Livingston B; Van Nest G
    J Leukoc Biol; 2007 Sep; 82(3):497-508. PubMed ID: 17565046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic agonists of Toll-like receptors 7, 8 and 9.
    Agrawal S; Kandimalla ER
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1461-7. PubMed ID: 18031246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells.
    Ehlin-Henriksson B; Mowafi F; Klein G; Nilsson A
    Immunology; 2006 Mar; 117(3):379-85. PubMed ID: 16476057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CL097, a TLR7/8 ligand, inhibits TLR-4--dependent activation of IRAK-M and BCL-3 expression.
    Petricevic B; Wessner B; Sachet M; Vrbanec D; Spittler A; Bergmann M
    Shock; 2009 Nov; 32(5):484-90. PubMed ID: 19333135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.